We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Fractional exhaled nitric oxide (FeNO): the future of asthma care?
- Authors
Wang, Kay; Stonham, Carol; Rutherford, Christine; Pavord, Ian D
- Abstract
The article discusses the potential use of fractional exhaled nitric oxide (FeNO) testing in the management of asthma. FeNO is a non-invasive breath test that measures airway inflammation, which is a key factor in asthma exacerbations. The article highlights the need for a more personalized approach to asthma care, based on individual disease mechanisms rather than diagnostic labels. The use of FeNO testing has shown promise in guiding asthma management, with studies suggesting that it can lead to a reduction in exacerbations and more tailored treatment plans. However, further research is needed to develop efficient and sustainable clinical pathways for FeNO testing in primary care. The article also discusses the barriers to implementing FeNO testing, such as financial challenges and differences in clinical practice guidelines. Overall, FeNO testing has the potential to improve asthma management in the community, but more research and infrastructure are needed to support its widespread use.
- Subjects
NITRIC oxide; ASTHMA; BREATH tests; PRIMARY care; VOCAL cord dysfunction; WHEEZE
- Publication
British Journal of General Practice, 2023, Vol 73, Issue 737, p565
- ISSN
0960-1643
- Publication type
Article
- DOI
10.3399/bjgp23x735813